Advanced search×

Absence of pharmacokinetic interactions of the combined contraceptive vaginal ring NuvaRing with oral amoxicillin or doxycycline in two randomised trials.

Peter P Dogterom, Michiel W MW van den Heuvel, and Torben T Thomsen

Clin Pharmacokinet 44(4):429-38 (2005) PMID 15828855

Two pharmacokinetic studies were performed to investigate whether there is any interaction between etonogestrel or ethinylestradiol released from the combined contraceptive vaginal ring NuvaRing and concomitant treatment with orally administered amoxicillin or doxycycline.

Version: za2963e q8za4 q8zbb q8zcc q8zd9 q8zeb q8zf9 q8zg6

Similar articles you may find interesting…

  1. The combined contraceptive vaginal device (NuvaRing): a comprehensive review.
    N N NN Sarkar

    Eur J Contracept Reprod Health Care 10(2):73-8 (2005) PMID 16147810

    NuvaRing is an effective vaginal contraceptive option for women. However, further study is needed for monitoring its long-term effectiveness and impact on patient's quality of life since the NuvaRing is marketed in many countries....
  2. The combined contraceptive vaginal ring (NuvaRing): first experience in daily clinical practice in The Netherlands.
    Frans J M E FJ Roumen, Monique M T MM op ten Berg, and Eric H M EH Hoomans

    Eur J Contracept Reprod Health Care 11(1):14-22 (2006) PMID 16546812

    In The Netherlands, the first clinical experiences with NuvaRing in daily practice confirm that the contraceptive ring is a reliable, safe, and convenient method of contraception....